Federal Drug Price Negotiations, Perverse Incentives, and Medicare Reforms
Analysis of federal drug price negotiations under the Inflation Reduction Act, examining perverse incentives in Medicare and private insurance, and exploring Medicare Advantage reforms to improve market efficiency and patient coverage.